New products are an essential component of our range. Introductions are made on an ongoing basis, with hundreds of new small molecules, peptides and antibodies being added every year. Our aim is to find the latest, otherwise unobtainable research tools, and bring them to the market as quickly as we can.
Cat.No. | Product Name | Activity |
5764 | Deferoxamine mesylate | Iron chelator; also hypoxia mimetic |
5763 | (R)-Citalopram oxalate | Enantiomer of escitalopram oxalate |
5752 | PF 06260933 dihydrochloride | MAP4K4 (HGK) inhibitor; also inhibits MINK and TNIK |
5647 | MI 192 | Potent and selective HDAC2/3 inhibitor |
5645 | IPSU | OX2 receptor antagonist; orally bioavailable |